• Subscribe
  • Webinars
  • White Papers
  • Buyer's Guide
  • PhotonicsNXT
  • Get Published!
    • Recent Quotes
    My Watchlist
    Indicators
    BioOptics Stock Watch
    Markets
    Stocks
    ETFs
    Tools
    Overview
    News
    Currencies
    International
    Treasuries

    Biocept Inc (NQ: BIOC )

    N/A UNCHANGED
    Last Price Updated: 4:00 PM EDT, Oct 24, 2023 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    All News about Biocept Inc

    < Previous 1 2 3 4 5 6 Next >
    Earnings Scheduled For August 16, 2021
    Companies Reporting Before The Bell • Entera Bio (NASDAQ:ENTX) is likely to report earnings for its second quarter. • Data Storage (NASDAQ:DTST) is expected to... 
    Via Benzinga
    The Daily Biotech Pulse: AzurRx Jumps On Data, Agios' Regulatory Application For Mitapivat Accepted For Priority Review, FDA Nod For GlaxoSmithKline
    Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Aug. 17) AbbVie Inc. (NYSE: ABBV)... 
    Via Benzinga
    Exposures Product Safety
    Biocept Stock Drops Despite Clocking Q2 Sales Of $12M
    Biocept Inc (NASDAQ: BIOC) reported its second-quarter revenues of $12 million, compared to a mere $917,471 a year ago, but sharply missing the consensus of $17.76... 
    Via Benzinga
    The Daily Biotech Pulse: Lilly Reorganizes Business Units In Neuroscience Focus, Helius Medical Spikes On Breakthrough Designation, Ra Medical Sells Dermatology Business
    Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Aug. 16) Bio-Rad Laboratories, Inc... 
    Via Benzinga
    12 Health Care Stocks Moving In Tuesday's Pre-Market Session
    Gainers Forte Biosciences (NASDAQ:FBRX) stock increased by 16.38% to $27.7 during Tuesday's pre-market session. The market value of their outstanding shares is at $374... 
    Via Benzinga
    Biocept Reports Second Quarter 2021 Financial Results
    From Biocept, Inc.
    Via Business Wire
    The Week Ahead In Biotech (Aug. 15-21): Fate Therapeutics Data Readout, RenovoRx IPO In Focus Amid Tapering Earnings News Flow
    Biopharma stocks retreated in the week ending Aug. 13, defying the optimism that was found in the broader market. Earnings continued to dominate the headlines, with small-... 
    Via Benzinga
    Topics Initial Public Offering
    Exposures Securities Market
    Biocept to Report Second Quarter 2021 Financial Results and Host Investor Conference Call on August 16, 2021
    From Biocept, Inc.
    Via Business Wire
    Biocept Names David Karlander as Senior Vice President of Commercial Operations
    From Biocept
    Via Business Wire
    Medicare Issues Local Coverage Determination for Biocept’s Target Selector™ Breast Cancer Assay to Detect the HER2 Biomarker from Circulating Tumor Cells
    From Biocept, Inc.
    Via Business Wire
    Biocept Welcomes Linda Rubinstein and Antonino Morales to Board of Directors, Names Director Samuel Riccitelli as Chairman
    From Biocept, Inc.
    Via Business Wire
    12 Health Care Stocks Moving In Monday's After-Market Session
    Gainers NeuroBo Pharmaceuticals (NASDAQ:NRBO 
    Via Benzinga
    Biocept to Participate in Two July Investment Conferences
    From Biocept, Inc.
    Via Business Wire
    Biocept Receives South Korean Patent for Primer-Switch Platform Used to Identify Rare Genetic Mutations, Including Cancer Biomarkers
    From Biocept, Inc.
    Via Business Wire
    Biocept Joins the Russell Microcap® Index
    From Biocept, Inc.
    Via Business Wire
    Biocept Stock Moves Higher On Collaboration With Quest Diagnostics For Liquid Biopsy Testing For Lung Cancer Patients
    Biocept Inc (NASDAQ: BIOC) has collaborated with Quest Diagnostics Inc (NYSE: DGX) to provide laboratory testing services to Quest patients for its Target... 
    Via Benzinga
    Biocept to Collaborate with Quest Diagnostics to Provide Advanced NGS-Based Liquid Biopsy Testing for Patients with Lung Cancer
    From Biocept, Inc.
    Via Business Wire
    Biocept Receives More Than 420,000 Samples During First Year of Offering COVID-19 Testing Service
    From Biocept, Inc.
    Via Business Wire
    Biocept and CLEARED4 Collaborate to Develop New Service for Managing COVID-19 Testing and Results Reporting for Biocept Customers
    From Biocept, Inc.
    Via Business Wire
    Biocept to Present at the LD Micro Virtual Invitational XI Conference on June 9, 2021
    From Biocept, Inc.
    Via Business Wire
    Biocept Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
    From Biocept, Inc.
    Via Business Wire
    MedTech Round Up: Update On Johnson & Johnson, Becton Dickinson, Labcorp, Second Sight Medical, Biocept
    Johnson & Johnson's (NYSE: JNJ) Vision segment has won FDA approval for the first contact lenses designed to reshape the cornea curve and help treat... 
    Via Benzinga
    Exposures Product Safety
    12 Health Care Stocks Moving In Thursday's Pre-Market Session
    Gainers Palisade Bio (NASDAQ:PALI) shares moved upwards by 35.23% to $7.1 during Thursday's pre-market session. Lianluo Smart (NASDAQ:LLIT) shares rose 19.37% to $7.21... 
    Via Benzinga
    Biocept Reports First Quarter 2021 Financial Results
    From Biocept, Inc.
    Via Business Wire
    Biocept to Report First Quarter 2021 Financial Results and Host Investor Conference Call on May 12, 2021
    From Biocept, Inc.
    Via Business Wire
    Biocept to Supply COVID-19 Testing Through Partnership With the Foundation for California Community Colleges
    From Biocept, Inc.
    Via Business Wire
    The Daily Biotech Pulse: Minerva, InflaRx Report Positive Data Readouts, Lucira COVID-19 Test Kit Available On Amazon, Decision Day For Heron
    Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs May 11) HOOKIPA Pharma Inc. (NASDAQ... 
    Via Benzinga
    Exposures COVID-19
    Earnings Scheduled For May 12, 2021
    Companies Reporting Before The Bell • PolyPid (NASDAQ:PYPD) is estimated to report earnings for its first quarter. • Boyd Gaming (NYSE:BYD) is projected to report... 
    Via Benzinga
    The Week Ahead In Biotech (May 9-15): Heron, Apellis FDA Decisions, Presentations and Earnings
    Biotech stocks came under pressure in the week ended May 7 as traders digested a slew of earnings news flow and a handful of clinical trial readouts. COVID-19 vaccine stocks came... 
    Via Benzinga
    Exposures COVID-19 Product Safety
    Biocept Announces Full Commercial Launch of CNSide™ Cerebrospinal Fluid Assay to Address Unmet Needs for Patients with Metastatic Brain Cancer
    From Biocept, Inc.
    Via Business Wire
    < Previous 1 2 3 4 5 6 Next >
    Data & News supplied by www.cloudquote.io
    Stock quotes supplied by Barchart
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the following
    Privacy Policy and Terms and Conditions.